Joel F. Sussman - May 1, 2025 Form 4 Insider Report for Galera Therapeutics, Inc. (GRTX)

Role
Chief Accounting Officer
Signature
/s/ J. Mel Sorensen, Attorney-in-Fact for Joel F. Sussman
Stock symbol
GRTX
Transactions as of
May 1, 2025
Transactions value $
$0
Form type
4
Date filed
5/5/2025, 04:19 PM
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sussman Joel F. Chief Accounting Officer C/O GALERA THERAPEUTICS, INC., 101 LINDENWOOD DRIVE, SUITE 225, MALVERN /s/ J. Mel Sorensen, Attorney-in-Fact for Joel F. Sussman 2025-05-05 0001774297

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRTX Stock Option (Right to Buy) Award $0 +2M $0.00 2M May 1, 2025 Common Stock 2M $0.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on June 1, 2025.